Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 38601-38650 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06791499
AI-Agent for Automated Diagnosis and Predicting Using EHR and Multimodal Data
N/ARecruiting
2,000,000 participants
Started: Jul 1, 2023 · Completed: Jul 31, 2025
1 condition1 sponsor6 locations
NCT06117631
Project Sueño: Sleep & Understanding Early Nutrition in Obesity
NARecruiting
240 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
6 conditions2 sponsors1 location
NCT06345131
Clinical Research Plan for the Safety and Accuracy of Ultrasound-guided Radial Artery Puncture Catheterization
NARecruiting
100 participants
Started: Jul 1, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05877573
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced,High-Risk,MSS Rectal Cancer
NARecruiting
53 participants
Started: Jul 1, 2023 · Completed: Aug 1, 2026
4 conditions2 sponsors1 location
NCT06417437
Non-invasive BCI and Application Verification for Depressed People
PHASE4Recruiting
400 participants
Started: Jul 1, 2023 · Completed: Jul 31, 2027
3 conditions5 sponsors1 location
NCT05838677
Pain at Work Toolkit in Employees With Chronic Pain
NARecruiting
120 participants
Started: Jul 1, 2023 · Completed: Nov 30, 2025
2 conditions6 sponsors1 location
NCT06068023
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
N/ARecruiting
400 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2029
1 condition2 sponsors1 location
NCT05962216
Real-life Assessment of Brexpiprazole (Rexulti) in Schizophrenia and in Depressive Disorders
N/ARecruiting
40 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2026
2 conditions2 sponsors1 location
NCT05919030
A Study of Chemoradiation in Combination with Tislelizumab As First Line Treatment in Participants with Advanced Esophageal Squamous Cell Carcinoma
PHASE3Recruiting
155 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT06075056
Neuro-navigated TMS for Chronic SCI Patients
N/ARecruiting
20 participants
Started: Jul 1, 2023 · Completed: Feb 1, 2024
1 condition2 sponsors1 location
NCT05797649
Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)
N/ARecruiting
120 participants
Started: Jul 1, 2023 · Completed: Nov 30, 2025
8 conditions2 sponsors1 location
NCT06146114
Single Center Registration Study on HER2 Expression and Clinical Pathological Characteristics in Prostate Cancer
N/ARecruiting
100 participants
Started: Jul 1, 2023 · Completed: Dec 1, 2024
1 condition1 sponsor1 location
NCT06386783
Fentanyl Versus Dexmedetomidine as an Adjuvant to Bupivacaine in Spinal Anesthesia ; Peritoneal Symptomatic Effects
PHASE3Recruiting
148 participants
Started: Jul 1, 2023 · Completed: Feb 25, 2025
2 conditions1 sponsor1 location
NCT05880251
Operant Conditioning of Sensory Brain Responses to Reduce Phantom Limb Pain in People With Limb Amputation
NARecruiting
20 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2025
5 conditions1 sponsor1 location
NCT05925504
The Tapering Dose of Luspatercept in Patients With Lower-risk Myelodysplastic Syndromes
PHASE2Recruiting
36 participants
Started: Jul 1, 2023 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT05963126
Fetuin A as a Predictor of Deterioration of Renal Function in Hypertonic Patients
N/ARecruiting
200 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05879029
Clinical Study of Jinsang Liyan Capsules Combined With PPI in the Treatment of LPRD
PHASE4Recruiting
72 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2024
1 condition2 sponsors1 location
NCT06791421
AI-Driven Genotype Prediction Using EHR and Multimodal Data
N/ARecruiting
100,000 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor4 locations
NCT05935436
Cardiac Shock Wave Therapy for the Treatment of Myocardial Infarction With Non-obstructive Coronary Arteries
NARecruiting
56 participants
Started: Jul 1, 2023 · Completed: Jun 20, 2025
2 conditions2 sponsors1 location
NCT05660746
Precise Infliximab Exposure and Pharmacodynamic Control
PHASE2/PHASE3Recruiting
180 participants
Started: Jul 1, 2023 · Completed: Mar 31, 2027
1 condition3 sponsors11 locations
NCT06406933
Salivary Conductivity Screening for Dry Eye Disease and Sjögren's Syndrome
N/ARecruiting
200 participants
Started: Jul 1, 2023 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05501990
Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients
NARecruiting
800 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06076850
Low-Intensity Extracorporeal Shockwave Therapy for Penile Rehabilitation in Post-Radical Prostatectomy Patients
NARecruiting
70 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06186609
PD-1 Inhibitor Combined With Radiotherapy for Elderly ESCC
PHASE2Recruiting
68 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06160310
Tuberous Sclerosis Complex and Lymphangioleiomyomatosis Pregnancy Registry (TSC-LAM Registry)
N/ARecruiting
300 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2029
2 conditions1 sponsor1 location
NCT05722782
Oral NSAI Versus Acetaminophen or Placebo as a Discharge Treatment of Non Complicated Renal Colics
PHASE2Recruiting
500 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT07172880
Pregnancy 24/7 Offspring Study
N/ARecruiting
800 participants
Started: Jul 1, 2023 · Completed: Jul 6, 2027
1 condition4 sponsors3 locations
NCT05866432
Phase II Study of Dato-DXd in Triple-negative Breast Cancer Patients With Newly Diagnosed or Progressing Brain Metastases
PHASE2Recruiting
20 participants
Started: Jul 1, 2023 · Completed: May 23, 2026
1 condition2 sponsors1 location
NCT06429293
Impact of Cognitive Behavioral Therapy on PTSD-CVD Link
NARecruiting
30 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT06452992
Microbiome and Metabolomics Profiling in Children With OSA
N/ARecruiting
130 participants
Started: Jul 1, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT06148116
Attitudes and Knowledge of Dialysis Patients Towards Kidney Transplantation
N/ARecruiting
2,000 participants
Started: Jul 1, 2023 · Completed: Sep 30, 2024
1 condition1 sponsor1 location
NCT05411341
Comparison of Two Different Optical Biometric Systems
N/ARecruiting
100 participants
Started: Jul 1, 2023 · Completed: Aug 31, 2024
4 conditions1 sponsor1 location
NCT06320600
Precision Medicine of Diabetes Program in China
N/ARecruiting
120,000 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05974176
Considering Racial and Acculturation Stress in Addressing Trauma
NARecruiting
237 participants
Started: Jul 1, 2023 · Completed: Aug 1, 2027
1 condition2 sponsors1 location
NCT07111325
Safety and Preliminary Efficacy of iEVs Injection in Treating Lateral Epicondylitis of Humerus
PHASE1/PHASE2Recruiting
24 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05901974
Venetoclax Combined With Azactidine in the Treatment of ALAL
PHASE2Recruiting
23 participants
Started: Jul 1, 2023 · Completed: Dec 1, 2025
1 condition7 sponsors1 location
NCT05910281
Rebound Pain and Related Factors in Postoperative Patients With Total Knee Arthroplasty
N/ARecruiting
150 participants
Started: Jul 1, 2023 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT06506786
Garden-fresh Foods and Gut Microbiomes
NARecruiting
20 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06071364
Morphological Changes in Back Muscles With Low Back Pain Patients
N/ARecruiting
58 participants
Started: Jul 1, 2023 · Completed: Jan 31, 2024
1 condition2 sponsors1 location
NCT05830266
Mother-infant Bonding in the Brain: a Mindfulness-based Intervention
NARecruiting
64 participants
Started: Jul 1, 2023 · Completed: Sep 30, 2026
3 conditions1 sponsor1 location
NCT06287541
The Necessity of a Second Transurethral Resection in High-risk Non-muscle-invasive Bladder Cancer Patients With Negative Urine Biomarker After Initial Transurethral Resection
NARecruiting
428 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2027
1 condition1 sponsor1 location
NCT05922007
The Effect of Chronic Pain and Its Treatment on Quality of Life and Physical Activity
N/ARecruiting
150 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05800379
Study on Hospitalization of Children With Bronchial Asthma
N/ARecruiting
470 participants
Started: Jul 1, 2023 · Completed: Apr 1, 2025
1 condition1 sponsor1 location
NCT05598450
rTMS for Auditory Hallucinations Guided by Magnetoencephalography
NARecruiting
60 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06282237
Clinical Evaluation, Motor Performance and Quality of Life in Patients Affected by Soft Tissue Sarcomas, Undergoing Surgical Treatment: Observational Study
N/ARecruiting
13 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition2 sponsors1 location
NCT06134791
Differences in Characteristics of Headache Patients With a Positive or Negative FRT: a Cross-sectional Comparison.
N/ARecruiting
100 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05704101
NHFT Effects on Symptatheic Drive of Asthma Patients
N/ARecruiting
30 participants
Started: Jul 1, 2023 · Completed: May 31, 2024
1 condition2 sponsors1 location
NCT06379412
A Cross-sectional Study on the Association of Peptidoglycan Fragments Derived From Gut Microbiota With Colorectal Cancer
N/ARecruiting
200 participants
Started: Jul 1, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06051851
Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer
PHASE2Recruiting
177 participants
Started: Jul 1, 2023 · Completed: Jul 1, 2026
1 condition1 sponsor1 location
NCT06528626
Tools to Identify People At Risk or Already Infected with HIV and HCV
NARecruiting
240,000 participants
Started: Jul 1, 2023 · Completed: Dec 1, 2025
3 conditions3 sponsors1 location